New chemo cocktail aims to tame advanced head and neck cancer

NCT ID NCT07361133

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether a combination of two chemotherapy drugs, cyclophosphamide and etoposide, can control advanced head and neck cancer in adults who have already tried standard treatment. 120 participants will receive either the drug combo or methotrexate for 6 months. Researchers will track tumor size, symptoms, and side effects to see if this approach is effective and safe.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
cyclophosphamide and etoposide (chemotherapy drugs)
What this could lead to
If it works, this could offer a new treatment option for patients with advanced head and neck cancer who have run out of standard options.
What could go wrong
This is a small, early-phase trial (phase 2) with only 120 participants. The drugs may not work better than existing treatments, and side effects from chemotherapy can be serious.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Head and Neck Neoplasms head and neck squamous cell carcinoma Neoplasm Metastasis Recurrence squamous cell carcinoma Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Cancer Institute

    Cairo, Cairo Governorate, 11796, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.